Pharmala Biotech Holdings Inc. rose 10.0% on Monday, November 9, 2026, on 46,132 shares. The headline around the move:
Pharmala Biotech Holdings Inc. (MDMA:CSE) closed at $0.145 on November 13, 2026, unchanged on the day. The stock trades 56.1% below its 52-week high of $0.330 and 70.6% above its 52-week low of $0.085. Over the past year, it gained 26.1%. Pharmala Biotech Holdings Inc. is part of the Life Sciences sector.
In 252 trading sessions since November 13, 2025, MDMA closed higher on 91 days (36%). Its best day was April 20, 2026 (+80.00%) and its worst was September 15, 2026 (-19.67%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 8 times.
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions.
Find more stocks like MDMA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.